(LOGC) Logicbio Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Logicbio Therapeutics | (LOGC) share price targets
Complete technical analysis of Logicbio Therapeutics (LOGC) by charts plus indicators, forecast predictions and share price targets for Logicbio Therapeutics (LOGC)
Logicbio Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-09-05 View latest technical analysis
10 day averaged volume of Logicbio Therapeutics is 206725
| Date | Daily Closing Price | Open | High | Low | Volume |
| 05 Thu Sep 2024 | 5.21 | 5.20 | 5.33 | 5.19 | 0.939 times |
| 04 Wed Sep 2024 | 5.18 | 5.16 | 5.26 | 5.15 | 1.037 times |
| 03 Tue Sep 2024 | 5.20 | 5.31 | 5.37 | 5.12 | 1.906 times |
| 30 Fri Aug 2024 | 5.40 | 5.42 | 5.46 | 5.37 | 0.582 times |
| 30 Fri Aug 2024 | 5.40 | 5.42 | 5.46 | 5.37 | 0.584 times |
| 29 Thu Aug 2024 | 5.43 | 5.46 | 5.52 | 5.37 | 0.868 times |
| 28 Wed Aug 2024 | 5.43 | 5.39 | 5.43 | 5.36 | 0.788 times |
| 27 Tue Aug 2024 | 5.43 | 5.45 | 5.49 | 5.34 | 0.558 times |
| 26 Mon Aug 2024 | 5.50 | 5.45 | 5.51 | 5.41 | 0.877 times |
| 23 Fri Aug 2024 | 5.48 | 5.35 | 5.55 | 5.32 | 1.676 times |
Although my analysis for stock is bearish for shortterm, but stock is in heavy over sold zones and there are high chances of some recovery tomorrow. You might want to buy the stock tomorrow in intra day with a stoploss of 5.2, for a target of 5.3 or 5.4
Share price targets for Logicbio Therapeutics (LOGC)
| Target Type | Value |
| Downside Target | 4.92 |
| Downside Target | 5.12 |
| Upside Target | 5.25 |
| Upside Target | 5.46 |
| Upside Target | 5.52 |
| Upside Target | 5.58 |
| Upside Target | 5.61 |
| Upside Target | 5.85 |
| Upside Target | 6.05 |
| Upside Target | 6.29 |
Intraday share price targets for Logicbio Therapeutics (LOGC)
| Target Type | Value |
| Downside Intraday Target | 5.1 |
| Downside Intraday Target | 4.98 |
| Upside Intraday Target | 5.35 |
| Upside Intraday Target | 5.48 |
| Upside Intraday Target | 5.23 |
Weekly technical analysis of Logicbio Therapeutics (LOGC)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 05 Thu Sep 2024 | 5.21 | 5.31 | 5.37 | 5.12 | 6.667 times |
| 30 Fri Aug 2024 | 5.40 | 5.42 | 5.46 | 5.37 | 0.158 times |
| 30 Fri Aug 2024 | 5.40 | 5.45 | 5.52 | 5.34 | 0.557 times |
| 23 Fri Aug 2024 | 5.48 | 5.48 | 5.61 | 5.32 | 1.094 times |
| 16 Fri Aug 2024 | 5.44 | 5.35 | 5.58 | 5.25 | 0.572 times |
Price has moved down this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Logicbio Therapeutics (LOGC)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 05 Thu Sep 2024 | 5.21 | 5.31 | 5.37 | 5.12 | 0.12 times |
| 30 Fri Aug 2024 | 5.40 | 5.44 | 5.61 | 4.92 | 1.067 times |
| 31 Wed Jul 2024 | 5.40 | 5.59 | 6.29 | 5.34 | 0.604 times |
| 28 Fri Jun 2024 | 5.71 | 5.38 | 6.05 | 5.31 | 1.706 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Logicbio Therapeutics (LOGC)
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Logicbio Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Logicbio Therapeutics in short term and the sell signal is strong.
Logicbio Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Logicbio Therapeutics in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Logicbio Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 5.35 and Logicbio Therapeutics (LOGC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Logicbio Therapeutics (LOGC) stock. Volume based technical analysis of Logicbio Therapeutics (LOGC) stock is negative.
Logicbio Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Logicbio Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Logicbio Therapeutics in short term and the sell signal is strong.
Logicbio Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Logicbio Therapeutics in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Logicbio Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 5.35 and Logicbio Therapeutics (LOGC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Logicbio Therapeutics (LOGC) stock. Volume based technical analysis of Logicbio Therapeutics (LOGC) stock is negative.
Logicbio Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.